BRD2 and leukemia: In a study that involved 73 patients with NHL, HL, leukemia, testicular cancer, sarcoma, and neuroblastoma with post-CT azoospermia, the mean FSH (21.9 mUI/mL), TT (354.4 ng/dL), and testicular volumes (9.1/mL) before m-TESE were predictive factors both for m-TESE and ICSI, as in our study [17].